SOURCE: Lifeline Biotechnologies, Inc.

April 11, 2006 11:11 ET

Today Is the Final Day to Qualify for Lifeline Biotechnologies' Stock Dividend

RENO, NV -- (MARKET WIRE) -- April 11, 2006 -- Lifeline Biotechnologies, Inc. (OTC: LBTN) announced that today is the final day for investors to qualify for the Company's Stock Dividend. Lifeline Biotechnologies recently announced that May 1, 2006 will be the date on which the stock dividend will be issued to its shareholders of record as of April 14, 2006.

The dividend will total an estimated 50 Million unrestricted shares of LBTN. Lifeline Biotechnologies' shareholders are expected to receive approximately one and a half shares of LBTN for every ten shares already owned on the record date.

"This is a very exciting time for our Company and our shareholders. We are very pleased by the response that we have received from investors and we look forward to the continued growth and development of our products and our Company," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's technologies, designed to assist in the early detection of cancers, deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care. The MastaScope™ is used to assist in the early detection of cancer and other abnormalities of the breast. The MastaScope™ has completed development and has entered the marketplace in the US and internationally. The First Warning System™ for assisting in the early detection of breast cancer and the OvaScope™ for assisting in the early detection of ovarian cancer are continuing to be developed by the company. More information is available at the company's website: www.lbti.com.

Safe Harbor This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Big Apple Consulting USA, Inc.
    for Lifeline Biotechnologies, Inc.
    Investor Relations
    Rodney Marvel
    407-884-0444
    or
    1-866-THE-APPLE